Cholesterol-lowering medications reduce the risk of age-related maculopathy progression

Med J Aust. 2001 Sep 17;175(6):340. doi: 10.5694/j.1326-5377.2001.tb143604.x.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Anticholesteremic Agents / therapeutic use*
  • Female
  • Humans
  • Macular Degeneration / epidemiology*
  • Macular Degeneration / prevention & control*
  • Male
  • Middle Aged
  • Victoria / epidemiology

Substances

  • Anticholesteremic Agents